Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2026

Fair Value Disclosures [Abstract]

Schedule of Level 3 Investments

The table below presents activity within Level 3 of the fair value hierarchy, our liabilities carried at fair value relating to the medac settlement, for the three months ended March 31, 2026:

	Level 3
(In thousands)	Contingent liabilities
Balance at January 1, 2026	$	864
Change due to liability payment	—
Liability fair value adjustment	—
Total change in foreign exchange	(19)
Balance at March 31, 2026	$	845

Schedule of Financial Assets and Liabilities Measured at Fair Value

The following tables present information about the Company’s financial assets and liabilities that have been measured at fair value as of March 31, 2026 and December 31, 2025 and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value.

	March 31, 2026
(In thousands)	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets:
Money market funds	$	1	$	—	$	—	$	1
U.S. government agency bonds	—		47,986		—		47,986
Total Assets	$	1	$	47,986	$	—	$	47,987
Liabilities:
Contingent Liability	$	—	$	—	$	845	$	845
Total Liabilities	$	—	$	—	$	845	$	845

	December 31, 2025
(In thousands)	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets:
Money market funds	$	2	$	—	$	—	$	2
U.S. government agency bonds	—		47,582		—		47,582
Total Assets	$	2	$	47,582	$	—	$	47,584
Liabilities:
Contingent Liability	$	—	$	—	$	864	$	864
Total Liabilities	$	—	$	—	$	864	$	864